Health Care Innovations Grants

Rolex Awards for Enterprise

The next Rolex Awards for Enterprise will be presented in 2012 to five new Laureates for their projects that demonstrate innovative thought and benefit the world we live in. For their new ventures or completion of ongoing projects, each Laureate receives US$100,000, a Rolex chronometer, and the benefits of international publicity.

Is your project eligible?

The Rolex Awards are open to any individual of any age, with a concrete working project. Proposals may be submitted in almost any area of activity, including science and health; applied technology; exploration and discovery; the environment; and cultural heritage.

How to Apply

To apply, after reading the Rules and Conditions, create an account and fill out a pre-application form. You will have one month, from the moment your account is created, to complete the pre-application form in English.

The final deadline for submitting a pre-application is 31 May 2011. However, you are strongly advised to submit a pre-application form as soon as possible.

Pre-applicants whose projects are selected by Rolex for further consideration will be invited to submit a full application.

The Rolex Laureates are selected by an independent panel of international specialists at the top of their fields, supported by a team of researchers.

Winners are chosen based on three main criteria: spirit of enterprise, originality, and potential impact. Judges also consider how the award will contribute to the completion of the project.

The Jury changes for each cycle of Rolex Awards. The 2012 jury will be announced in 2011.

Since 1976, more than 100 leading experts from 24 countries have served on the Rolex Awards Jury. They include French research virologist Professor Luc Montagnier, Russian deep-ocean explorer Anatoli Sagalevitch and American astronaut and educator Dr Katherine Sullivan.

National Patient Safety Foundation’s Research Grants Program

NPSF Call for Letters of Intent to Conduct Research and Development in Patient Safety

Applications invited for grant projects to begin in 2011

Letter of Intent deadline: September 10, 2010

The National Patient Safety Foundation’s Research Grants Program seeks to stimulate new, innovative projects directed toward enhancing patient safety in the United States. The Program’s objective is to promote studies leading to the prevention of human errors, system errors, patient injuries, and the consequences of such adverse events in the healthcare setting. In this first stage of a two-stage application process, Letters of Intent (LOIs) are solicited for research and development that is broadly related to identifying the causes of preventable injuries and errors and/or developing prevention strategies and methods to implement them. Based on these LOIs, a limited number of applicants will be invited to submit a full proposal.

While projects that promise improved methods of patient safety with a defined and direct path to implementation into patient care settings are encouraged, of equal importance are studies of problems for which deeper understanding is needed before effective solutions can be applied. Patient care setting is considered to be any environment in which health care is provided, including but not limited to inpatient, outpatient, extended care, and home care.

Innovation and creativity are strongly encouraged, as are cross-disciplinary research teams. Because the resources of NPSF are limited, priority will be given to topics that do not have other available sources for funding. For more information, please review the Agenda for Research and Development in Patient Safety at www.npsf.org/r/npsfrd/.
NPSF research funding is made possible in part by generous contributions from NPSF Board members through their support of the NPSF Board Grant. NPSF promotes co-sponsorship initiatives with other organizations in order to increase available funding for research.

About NPSF
NPSF has been diligently pursuing one mission since its founding in 1997 – to improve the safety of the healthcare system for the patients and families it serves. NPSF is an independent, non-profit 501(c)(3) organization, and is unwavering in its determined and committed focus on uniting disciplines and organizations across the continuum of care, championing a collaborative, inclusive, multi-stakeholder approach. For more information please visit www.npsf.org.

Eligibility Requirements and Funding Availability
Awards are made to a sponsoring institution, not to individuals or departments. Applicants must be official members of a non-profit institution in the United States. Eligibility is limited to projects whose principal investigators (PIs) have not received funding as the PI of an NPSF research grant within the past three years. While there is no limit to the number of applications that may be submitted per individual or institution, NPSF will award funding to no more than one proposal per PI in a given funding cycle.

The maximum award amount is $100,000 for the entire term of the project. The maximum indirect cost rate is 15% of total direct costs, excluding equipment, and must be included in the total $100,000 maximum award. Projects may be for up to 2 years in duration. The number of grants to be awarded will depend on the nature and quality of applications received and the total funds available. In the 2010 cycle a total of 125 LOIs were received of which two were selected for funding; total funding awarded was $199,918.00.

Application Deadline
All LOI materials must be received by NPSF no later than September 10, 2010. Late arrivals will not be accepted.

Letter of Intent Format
Each application must be delivered to NPSF as five hard copies of the LOI (one original plus four copies) and an electronic copy of the LOI on CD-ROM (no email submissions). Format the electronic version as a single file in MS Word or PDF format. The LOI must be no longer than three single-sided pages, single-spaced, with a 12 pt. font size and with 1-inch margins on all sides. All pages must be numbered and include a footer with the Principal Investigator’s name. Cover letter, Research Design and Subject Area, CV, and Bibliography are not part of the three page limit. The LOI should be organized as follows:

Cover Letter: On letterhead of the institution that is sponsoring the investigation.

Title and Principal Investigator (PI): Include title of the project, the credentials, title, office address, and email address of the PI, and the PI’s primary institutional affiliation. List only one person as the PI. Identify all co-investigators, collaborators, and consultants as described below under Qualifications of Key Individuals.

Research Design and Subject Area: Please provide information about the design and disciplinary focus of the proposed research. Go to www.npsf.org/r/ to complete this required component of the application.
Executive Summary: Summarize the project. Limit to one paragraph.

Background: Describe the problem, existing knowledge about it, its importance to patient safety, and its relevance to the goals of the NPSF. Limit to 2 paragraphs.

Specific Aims: Describe what you are proposing to accomplish toward addressing the problem, i.e., what are your goals and objectives?

Methods: Describe the methods that will be employed to study the problem. Be as specific as possible without unnecessary detail. This section should be about one page, i.e., it is important to emphasize methods more than Background.

Impact: Describe how you expect the results will be used and what impact could they have in addressing the problem.

Estimated Budget and Timeline: Detail the estimated costs and indicate any funds that will be provided by the institution or other entities. Outline the timeline for completion of the work.

Qualifications of the Key Individuals Involved: Include a CV or biographical sketch of the principal investigator (2 pages maximum), listing only most relevant publications. A CV of one co-investigator (2 pages maximum) may be included if this is deemed necessary. Name other members of the research team, which should include persons from the appropriate disciplines; interdisciplinary teams are strongly encouraged. Comment on institutional support and any special characteristics.

Bibliography: Include the references of publications relevant to proposed study (one page maximum).
Do not attach any appendices. They will not be forwarded to reviewers.

Review and Announcement of Finalists
A multidisciplinary team of experts will evaluate the LOIs. Investigators will be notified of the status of their LOIs no later than November 22, 2010. The Foundation will not provide individual critiques of LOIs that are not invited to submit a full proposal.

In the second stage of the process, a limited number of applicants will be invited to submit a full proposal, for which more detailed instructions will be provided. Full proposals will be due January 31, 2011. Grant recipients will be notified no later than April 11, 2011.

Please send your hard copies and CD-ROM of the Letter of Intent to:

National Patient Safety Foundation
Attn: Anita Spielman
268 Summer Street, Sixth Floor
Boston, MA 02210

For more information: 617-391-9900

International Association for Dental Research Wilmer Souder Award

Supported by the William T. Sweeney Memorial Fund & by the IADR Dental Materials Group

Initiated in 1955, this is the oldest of the Science Awards. The award honors Dr. Wilmer Souder, the motivating force in establishing the Dental Section at the National Bureau of Standards (now the National Institute of Standards and Technology), and is designed to perpetuate the scientific ideals which he exemplified, and to encourage interest in dental materials research. The award is made on the basis of scientific achievement of outstanding quality which has advanced or may reasonably be expected to significantly advance dental service to the public. It is intended to confer the highest honor in the field of dental materials research upon those scientists who, through research in this field, bring about outstanding advances in dental health. Established by IADR’s Dental Materials Group, and supported by the William T. Sweeney Memorial Fund and the Group, the award consists of a cash prize and a plaque.

IADR Distinguished Scientist Awards

The deadline for nominations is 11:59pm (HST) on Friday, September 3, 2010.

Begin a Submission: http://dsa.confex.com/dsa/dsa2011/awards/papers/index.cgi
Login to a previously begun submission: http://dsa.confex.com/dsa/dsa2011/login.htm

About:
The Science Awards Committee has the responsibility of selecting awardees from among the nominations of renowned scientists submitted by Association members. The Committee consists of the Science Awards chair and the subcommittee chair for each award. The subcommittee members are composed of the previous award recipients. Appointments are made annually for a period of five years on a rotation basis. Any IADR member may nominate a candidate for a science award. Once a nomination is made, it is considered each year for five years unless the nominee is selected for an award during this period. After the fifth year, the nomination is withdrawn unless a re-nomination is received.

Eligibility:

Science Awards subcommittees are composed of previous winners of the awards; therefore, subcommittee members may not be nominated again for the same award. Members of Science Awards subcommittees may be nominated by another subcommittee. Subcommittee members who have been appointed by the IADR President-elect and who have not already received their subcommittee's award may be nominated for any award; however, appointees must resign if nominated for the award of the subcommittee on which they currently serve.

ONLY IADR members may be nominated.
Posthumous nominations are not acceptable.
Nomination of an individual for more than one award in the same year is discouraged.
No person should be awarded two IADR Science Awards for the same research, with the exception of the Edward H. Hatton and Young Investigator Awards. Any nominations for a second award must include written evidence that the nomination is for work in a different field of research.
Nomination of current IADR and Division Officers is discouraged.
All nominations made within the past five years must be reconsidered in the current selection unless the nominee was selected for an award.

Procedures:
Any IADR member may nominate a candidate for a science award. All nominations must be submitted via the online system.
The following information MUST accompany each nomination and submitted electronically.

Only nominations submitted online will be accepted.

1. Short statement (no more than 700 words) describing the reasons you are nominating the individual for the particular award; and
2. Curriculum vitae

name,
address,
date and place of birth,
education,
honors,
employment,
membership in professional organizations,
bibliography, and
summary of specific scientific contributions of the candidate.

Award: The award consists of a $3,500 cash prize and a plaque presented at Opening Ceremonies of the IADR General Session & Exhibition.

Contact:
Sheri S. Herren
Awards, Fellowships & Grants Manager
sherren@iadr.org

International Association for Dental Research
1619 Duke Street
Alexandria, VA 22314-3406

Phone: +1.703.548.0066
Fax: +1.703.548.1883

Cytopathology Research Seed Grant

The ASC Foundation will grant $30,000 to a qualified young cytopathology professional (ASC Member) with no more than five years since completion of training, to conduct important research in cytopathology and attend the ASC Annual Scientific Meeting. The Grant will be presented every two years. Eligibility requires demonstration of commitment to ongoing research in cytopathology.

The goal of this grant is to stimulate innovative translational research using material obtained from routine cytology specimens with the aim of improving the quality of work done by cytologists, thereby enhancing patient care. This includes (but is not limited to) application of new technologies to cytopathology.

1. The applicant must demonstrate a commitment to ongoing research in cytopathology and have no more than five-year experience in cytopathology since completion of training.
2. A curriculum vitae that includes educational training indicating the time, place and degrees awarded, relevant awards and honors, and a complete bibliography (separately listing publications in peer reviewed journals, abstracts and other articles with authors listed in the original order of publication). (Limit five pages)
3. A proposed research plan (no more than three single-spaced pages with one-inch margins and no less than 11-point font). This document should be a summary of the proposed research project as well as any simultaneous training that will be obtained. The summary should include: 1) specific aims or hypotheses to be tested, 2) a brief introductory review giving the rationale for the research, 3) a section describing how the aims or hypotheses will be achieved with emphasis on experimental design over the details of the specific methods, and 4) a summary paragraph describing the goals of the work and how it could have impact on the practice of cytopathology in the future. Preliminary results supporting the research plan may be included or referenced, but are not absolutely required. Innovative approaches and new concepts that are framed into concise protocols will be favored. (Limit three pages)
4. A statement of career goals (Limit one page) describing the applicant’s short- and long-term career goals and how this award will enhance these career plans.
5. Mentor's letter of recommendation from an individual or mentor who is familiar with the applicant’s potential as an investigator. This letter should include information assuring that the mentor/sponsor has sufficient resources to facilitate the awardee and can support expenses beyond the $30,000 if the project incurs greater expenses. This letter should also include a statement that the Mentor or Applicant has an Internal Review Board approval for HIPAA compliant study of human samples, if applicable.

* Application material should be submitted in the order listed in this section. Pages should be numbered and submitted in page order. Applications must be typed using font no smaller than 11-point.
* The awardee will be selected on the basis of his/her qualifications and interest in research, reference from their mentors, and the selection committee’s evaluation of the potential professional benefit of the award to the candidates.
* The awardee will receive $30,000 to be used for research supplies and material expenses and travel expenses to the Annual Scientific Meeting following the year of the grant. Thus, no budget is required and no "overhead" or indirect costs will be provided to sponsoring institutions. The grant will be made to the Grants Office of the Institution at which the awardee is employed.

GRANT APPLICATION

*Deadline for submission of applications is August 15, 2010. Applicants will be notified of the Foundation Board’s decision in October 2010.

American Society of Cytopathology
100 West 10th Street Suite 605
Wilmington, Delaware 19801

Telephone: (302) 543-6583
Fax: (302) 543-6597

American Association for Cancer Research Richard and Hinda Rosenthal Memorial Award

AACR and the Rosenthal Family Foundation established this Award in 1977 to recognize research that has made, or promises to soon make, a notable contribution to improved clinical care in the field of cancer. In its desire to honor and provide incentive to investigators relatively early in their careers, the Foundation has stipulated that recipients not be more than 50 years of age at the time the Award is received.

The winner of the 35th Annual AACR Richard and Hinda Rosenthal Memorial Award will receive an honorarium of $10,000, give a 50-minute lecture during the AACR Annual Meeting 2011 in Orlando, FL, U.S.A. (April 2-6, 2011), and be given support for the winner and a guest to attend the Annual Meeting.

Eligibility

* Candidacy is open to cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Such institutions include those in academia, industry, or government.
* The Award will be presented to an individual investigator.
* Institutions or organizations are not eligible for the Award.
* Candidates must not be more than 50 years of age at the time the Award is received. For the 2011 Award, a candidate's date of birth must be on or after April 6, 1960.
* Candidates must be engaged in the practice of medicine.

Nomination Process

Nominations for the 2011 Award will open in August 2010.

Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.

Nominations must be submitted electronically to https://proposalcentral.altum.com, no later than 4:00 p.m. United States Eastern Standard Time on Friday, October 15, 2010. Paper nominations will not be accepted.

The following materials must be submitted:

Nomination Letter, which must:

* be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;
* specify the AACR Award for which the candidate is being nominated;
* a concise description of the candidate's research that has made, or promises to soon make, a notable contribution to improved clinical care in the field of cancer, with the publications supporting these accomplishments directly referenced within the letter; and
* a concise description of the impact of these accomplishments on the field.

Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.

Summary Statement. A statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.

Preferred file formats are *.doc. The candidate's CV may be submitted as a .pdf file. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within two business days.

Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.

Nomination Instructions

Will be available in August 2010.

Selection

Candidates will be considered by a Committee of international cancer leaders appointed by the President of the AACR. After careful deliberations by the Award Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the Award winner will be made on the basis of the candidate's contribution to improved clinical care in the field of cancer. No regard will be given to race, gender, nationality, or religious or political views.

Supporter

Generously supported by the Rosenthal Family Foundation.

Questions?

Monique P. Eversley, Program Coordinator
+1 (267) 646-0576; monique.eversley@aacr.org

American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404

Society of Interventional Radiology Foundation Academic Transition Grant

The Academic Transition Grant is designed for interventional radiologists over the age of 40 who have recently begun academic careers after spending several years in non-academic practice. The grant is intended to facilitate the establishment of a record of independent research by the investigator in order to promote a successful academic career.

Application Deadline: December 14, 2010

AWARD
This grant provides up to $25,000 to support a pilot or seed grant project that tests a new idea or helps support a new area or direction of research in interventional radiology.

ELIGIBILITY
Grants are available to full-time faculty, over 40 years of age, with a MD, DO or equivalent degree in educational institutions in the United States and Canada. Applicants must have completed three or more years of private or non-academic practice and show a commitment to applying those skills learned in private practice to research and academics. Only applicants who have been in academia five years or less and do not have any other research funding are eligible to apply. Applicants must be members of the Society of Interventional Radiology (SIR).

Applicants must be citizens of the United States or Canada or have permanent resident status therein. Permanent residents must submit documentation of this status.

APPLICATION PROCEDURES
Applicants should propose research that advances the science of interventional radiology. The application must contain a detailed research plan, including a one-year budget for the planned research. All funds requested in the application must be fully justified. Insufficient justification will result in deferral or disapproval of the application.

Applications of scientific merit not funded by the Academic Transition Grant will automatically be considered for funding by the Pilot Research Grant.

The proposal should include a cover letter from the applicant indicating how the proposed research project will assist in their transition from private practice to academia, and they understand that they are expected to do the majority of the work in the actual conduct of the proposed studies. In addition, a letter from the department chair must be provided that indicates approval of the application, comments on the merit of the project, and explains the extent to which the department is supporting the applicant’s research in terms of funding and/or available facilities. It is important that the chair’s letter indicate commitment to provide protected research time and support the salary of the applicant during the research period.

The application must be submitted electronically through the online application found at http://www.tfaforms.com/160162 by December 14. Applications must be submitted in PDF format. Incomplete applications and those submitted after the deadline of December 14 will not be reviewed.
 

Stanford University Biodesign Program Fellowship

Explore the basics of biomedical technology invention and implementation through an intensive fellowship at Stanford University.The Biodesign Program has two Fellowship teams each year with different specialty focus areas. Specialty areas in the past have included Cardiovascular Medicine, Neurosurgery/ Neurology, Electrophysiology, Musculoskeletal, Regenerative Medicine, Anesthesia/Critical Care, Gastroenterology and General Surgery.

Application deadlines for 2011 Fellowship is October 12, 2010.

Team Based: Multidisciplinary teams of four graduate and/or postgraduate engineers, business professionals, bioscientists and physicians collaborate in a process involving clinical immersion, identification and verification of clinical problems, invention, prototyping, early-stage testing, and project planning.

Problem-Based, Solution-Driven: Teams invent new technologies that address major clinical and surgical needs. In the past five years Biodesign Innovation teams have filed multiple patents, have introduced new technologies into clinical practice, have started new companies and have won major technology development awards.

Schedule: All of the fellows will complete a 10-month program, stipend supported. Surgeons will complete a second year regardless of first-year team assignment. Other fellows may have the opportunity to do a second year if they are working on a project and can secure funding.

Faculty & Mentors: In addition to Stanford clinical and engineering faculty, the teams are mentored by over 100 "real world" experts in design, prototyping, regulatory, reimbursement, finance and other aspects of technology implementation.

Characteristics: Desirable fellow characteristics include demonstrated leadership potential, evidence of innovation within medical technology, knowledge of medicine and public health, engineering and business and the ability to work in a team.

Candidates & Eligibility: Applicants with a background in engineering, medicine, biosciences or relevant business /technology are encouraged to apply. Masters, Medical or Doctorate degrees preferred. Resident/fellows in surgery who enjoy applying technology to solve unmet clinical needs and who thrive on the process of innovation are encouraged to apply for the Fellowship. Candidates will be judged in terms of potential to become leaders in biomedical technology innovation, including demonstrated potential for creativity, invention and implementation.

Stipend: All fellows are paid a monthly stipend and health benefits are provided.

Selection: Each academic year we select eight fellows. Individuals with a special interest in medical technology development are welcome to apply. Surgeons in their residency or fellowship training may apply to be on one of the teams.

Note: all interview travel costs are reimbursed.

Candidates selected to interview will be notified in late October, interviews will be held November 18, 19 and 20. Final selection of fellows will be announced by end of 2010.

World Health Summit and Pfizer Award for Innovation in Biomedical Research Medicine in Transition – Novel Applications of Personalized Medicine in Chronic Diseases

The scientific and medical solutions to the future delivery of healthcare will in large part be found by the young scientists of today. It is therefore critical that we appropriately recognize, encourage and reward the great science being done by the potential leaders of tomorrow’s scientific and medical research world.

Accordingly it is with great pleasure again in 2010 with Pfizer R&D we announce the “World Health Summit and Pfizer Award for Innovation in Biomedical Research”. This annual, international award endowed with Euro 75,000 is designed to recognise and reward young scientists at the outset of their career, promote innovation in biomedical research and encourage translation to benefits in human health.

In its scope, the award will recognize highly innovative independent research in biomedical science which promises to make a positive impact on human health. Special attention will be paid to the potential of the research to build into a program of activities and drive this “translational agenda”.

Eligibility

The award will be open to all research scientists who are

1) considered to be in the “training phase” of their careers and

2) just after exhibiting a valued experience in an academic institution.

To align with a key theme of the Summit, the first call is on:

“Medicine in Transition – Novel Applications of Personalized Medicine in Chronic Diseases”

The scientist’s work should show impact to address questions of health care of a high global impact and develop perspectives of clinical application to increase global health.

The selection of the winner will be undertaken by a panel comprising deans of the M8 institutions and a senior Pfizer scientist. The announcement of the winner will be made at the World Health Summit.

The application deadline is on July 31st, 2010.

Contact

For further details, please contact:
Dr. Mazda Adli
Charité Universitätsmediztin Berlin
World Health Summit Executive Secretary
mazda.adli(at)charite.de

Partnership for Clean Competition Research Grant Program

The Partnership for Clean Competition will support high-quality, high-impact, novel research that has a high likelihood of success and of resulting in methods or products that will advance the anti-doping field and ensure integrity in sport.

The PCC will review submitted pre-applications on a rolling basis. Applicants whose pre-applications align with PCC research objectives and show considerable potential will then be asked to submit full grant applications.

* Round 1: Pre-applications due March 1; Full applications due April 1
* Round 2: Pre-applications due July 1; Full applications due August 1
* Round 3: Pre-applications due November 1; Full applications due December 1

If you lack preliminary data to supply with your application, you may wish to apply for a one-year pilot project grant. Please indicate on your application if you are applying for a pilot project.

If you have any questions or concerns, please contact Jill Zeldin at (719) 238-5696 or jzeldin@cleancompetition.org.

Research Priorities

* Improving existing analytical methods to detect particular drugs, e.g.,:
o GH, IGF-1
o EPO
o hCG
o discrimination of exogenous and endogenous steroids
o screening methods for common steroids
o stimulants

* Developing analytical methods to detect performance enhancing drugs not currently detectable, e.g.,:
o Selective Androgen Receptor Modulators
o Identifying designer steroids
o Autologous blood transfusions
o Other forms of enhanced oxygen transport and use

* Discovering cost effective approaches for testing widely abused substances

* Longitudinal studies to document urinary excretion patterns, metabolism and dose-concentration

* Critical Reviews of the literature from which to develop Position Papers to support interpretation of laboratory data

* Alternative specimens, (e.g., hair, sweat, saliva, interstitial fluid) for testing

* Better understanding of how banned substances are used and the implications for the long-term health consequences of athletes

American College of Cardiology Foundation/GE Healthcare Career Development Awards in Cardiovascular Imaging Technologies and Targeted Imaging Agents

Description:
Two awards are available to foster the early research career development of junior cardiovascular faculty in the research area of imaging technologies and targeted imaging agents. These awards will furnish a portion of the faculty member's total salary support. It is anticipated that the balance of the salary will come from other sources.

Eligibility:
Applicants eligible for the award are those who: 1.) Will hold rank of instructor or assistant professor at the time of the initiation of the award and have completed adult, pediatric, surgical cardiology fellowship training in a program approved by the Accreditation Council for Graduate Medical Education (ACGME) or the American Osteopathic Association; 2.) Are members of the American College of Cardiology; 3.) Are no more than five (5) years out of training; 4.) Have the recommendation and agreement of their division chiefs and the chief's assurance that the awards' support will provide protected time for the applicants to pursue their research programs; and 5.) Have an agreement with their institutions that the full amount of the award will be designated for the salary support.

Selection:
Criteria for selection includes scientific quality of the project; Qualifications and commitment of the applicant; support of the environment to foster the proposed project and applicant's success.

The Award:
$65,000 each year for the funding of July 1, 2011 - June 30, 2013.

How to Apply: Please go to http://acc.gsubmit.net/cgi-bin/main.plex to submit an application.

Application Deadline: August 31, 2010

For More Information:

Contact Kelli Bohannon at 800-253-4636, ext. 6635 or kbohanno@acc.org for more information.

American College of Cardiology
Heart House
2400 N Street NW
Washington DC, 20037

Phone: (202) 375-6000
Fax: (202) 375-7000